Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
- PMID: 29948425
- PMCID: PMC6220676
- DOI: 10.1245/s10434-018-6558-7
Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Abstract
Background: After radical resection of pancreatic ductal adenocarcinoma (PDAC), approximately 80% of patients will develop disease recurrence. It remains unclear to what extent the location of recurrence carries prognostic significance. Additionally, stratifying the pattern of recurrence may lead to a deeper understanding of the heterogeneous biological behavior of PDAC.
Objective: The aim of this study was to characterize the relationship of recurrence patterns with survival in patients with resected PDAC.
Methods: This single-center cohort study included patients undergoing pancreatectomy at the Johns Hopkins Hospital between 2000 and 2013. Exclusion criteria were neoadjuvant therapy and incomplete follow-up. Sites of first recurrence were stratified into five groups and survival outcomes were estimated using Kaplan-Meier curves. The association of specific recurrence locations with overall survival (OS) was analyzed using Cox proportional-hazards models with and without landmark analysis.
Results: Accurate follow-up data were available for 877 patients, 662 (75.5%) of whom had documented recurrence at last follow-up. Patients with multiple-site (n = 227, 4.7 months) or liver-only recurrence (n = 166, 7.2 months) had significantly worse median survival after recurrence when compared with lung- (n = 93) or local-only (n = 158) recurrence (15.4 and 9.7 months, respectively). On multivariable analysis, the unique recurrence patterns had variable predictive values for OS. Landmark analyses, with landmarks set at 12, 18, and 24 months, confirmed these findings.
Conclusions: This study demonstrates that specific patterns of PDAC recurrence result in different survival outcomes. Furthermore, distinct first recurrence locations have unique independent predictive values for OS, which could help with prognostic stratification and decisions regarding treatment after the diagnosis of recurrence.
Conflict of interest statement
Figures


Comment in
-
ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?Ann Surg Oncol. 2018 Dec;25(Suppl 3):806-807. doi: 10.1245/s10434-018-6820-z. Epub 2018 Oct 8. Ann Surg Oncol. 2018. PMID: 30298312 No abstract available.
Similar articles
-
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.Ann Surg. 2018 May;267(5):936-945. doi: 10.1097/SLA.0000000000002234. Ann Surg. 2018. PMID: 28338509
-
Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.J Surg Oncol. 2020 Nov;122(6):1074-1083. doi: 10.1002/jso.26103. Epub 2020 Jul 16. J Surg Oncol. 2020. PMID: 32673436
-
Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.HPB (Oxford). 2019 Aug;21(8):998-1008. doi: 10.1016/j.hpb.2018.12.002. Epub 2019 Feb 15. HPB (Oxford). 2019. PMID: 30777697
-
Meta-analysis of recurrence pattern after resection for pancreatic cancer.Br J Surg. 2019 Nov;106(12):1590-1601. doi: 10.1002/bjs.11295. Epub 2019 Aug 27. Br J Surg. 2019. PMID: 31454073
-
Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.HPB (Oxford). 2016 Jan;18(1):21-8. doi: 10.1016/j.hpb.2015.07.009. Epub 2015 Dec 21. HPB (Oxford). 2016. PMID: 26776847 Free PMC article. Review.
Cited by
-
Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer: An International Expert Survey and Case-Vignette Study.Cancers (Basel). 2023 Nov 27;15(23):5603. doi: 10.3390/cancers15235603. Cancers (Basel). 2023. PMID: 38067306 Free PMC article.
-
Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis.J Clin Med. 2020 Jul 6;9(7):2132. doi: 10.3390/jcm9072132. J Clin Med. 2020. PMID: 32640720 Free PMC article.
-
Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer.Cancers (Basel). 2021 May 11;13(10):2285. doi: 10.3390/cancers13102285. Cancers (Basel). 2021. PMID: 34064540 Free PMC article.
-
Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.Intern Med. 2021 Jan 15;60(2):223-229. doi: 10.2169/internalmedicine.5449-20. Epub 2020 Sep 19. Intern Med. 2021. PMID: 32963157 Free PMC article.
-
The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma.Front Oncol. 2023 Feb 3;13:1078861. doi: 10.3389/fonc.2023.1078861. eCollection 2023. Front Oncol. 2023. PMID: 36816950 Free PMC article.
References
-
- Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21. - PubMed
-
- Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA,Hruban RH, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140:764–72. - PubMed
-
- Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220:530–6. - PubMed
-
- Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence afterresection for ductal adenocarcinoma of the pancreas. World J Surg. 1997;21:195–200. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical